- Nebraska Oncology Society
- The Nebraska Chapter of the American College of Cardiology
- Nebraska Rheumatology Society
- Medication-Assisted Treatment
- Nebraska Dermatology Society
- Nebraska Neurological Society
- Nebraska Radiological Society
- Nebraska Association of Pathologists
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy of New RET Inhibitors? Should We Use Them 1L or 2L?
By
Nebraska Oncology Society
FEATURING
Eric Sherman
By
Nebraska Oncology Society
FEATURING
Eric Sherman
30 views
January 5, 2021
Comments 0
Login to view comments.
Click here to Login
Nebraska Oncology Society